Your browser doesn't support javascript.
loading
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.
Ciccosanti, Fabiola; Di Rienzo, Martina; Romagnoli, Alessandra; Colavita, Francesca; Refolo, Giulia; Castilletti, Concetta; Agrati, Chiara; Brai, Annalaura; Manetti, Fabrizio; Botta, Lorenzo; Capobianchi, Maria Rosaria; Ippolito, Giuseppe; Piacentini, Mauro; Fimia, Gian Maria.
Afiliação
  • Ciccosanti F; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Di Rienzo M; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Romagnoli A; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Colavita F; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Refolo G; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Castilletti C; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Agrati C; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Brai A; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
  • Manetti F; Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
  • Botta L; Department of Ecological and Biological Sciences, University of Tuscia, Viterbo, Italy.
  • Capobianchi MR; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Ippolito G; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy.
  • Piacentini M; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy. Electronic address: mauro.piacentini@uniroma2.it.
  • Fimia GM; Department of Epidemiology, Preclinical Research and Advanced Diagnostics, National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome, Italy; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: gianmaria.fimia@inmi.it.
Antiviral Res ; 190: 105064, 2021 06.
Article em En | MEDLINE | ID: mdl-33781803
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / RNA Helicases DEAD-box / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / RNA Helicases DEAD-box / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article